BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (GEPPPGKPADDAGLV) derived from a partial sequence of body protection compound originally isolated from human gastric juice. It exhibits remarkable cytoprotective activity across multiple organ systems — gastric and intestinal mucosa, tendons, ligaments, bone, muscle, nervous tissue, and the cardiovascular system — without systemic toxicity at research doses. BPC-157's multi-target mechanism involves modulation of the nitric oxide (NO) system, upregulation of VEGF receptor-2 (VEGFR2) and EGF receptor signaling, activation of focal adhesion kinase (FAK) and paxillin pathways (driving cell migration and angiogenesis), and interaction with the growth hormone receptor pathway. In gastrointestinal research, BPC-157 accelerates healing of gastric ulcers, esophageal damage, and inflammatory bowel disease by enhancing mucosal blood flow, stimulating epithelial cell migration, and reducing pro-inflammatory cytokine production. Tendon and ligament repair studies demonstrate that BPC-157 upregulates collagen expression, promotes tenocyte proliferation, and dramatically accelerates healing of surgically transected tendons, cruciate ligaments, and rotator cuff injuries in animal models. The peptide also promotes angiogenesis at injury sites, restoring vascular supply essential for tissue regeneration. Neurological research has demonstrated BPC-157's neuroprotective properties in traumatic brain injury and spinal cord damage models, with evidence of dopaminergic and serotonergic system modulation. In muscle research, BPC-157 accelerates recovery from crush injuries, ischemia-reperfusion damage, and NSAID-induced toxicity. Its unique stability in gastric juice (unlike most peptides), combined with efficacy via multiple administration routes (oral, intraperitoneal, subcutaneous), makes BPC-157 a uniquely versatile research tool for systemic healing and cytoprotection studies.